A detailed history of Kingsbury Capital Investment Advisors LLC transactions in Matinas Bio Pharma Holdings, Inc. stock. As of the latest transaction made, Kingsbury Capital Investment Advisors LLC holds 119,949 shares of MTNB stock, worth $64,772. This represents 0.12% of its overall portfolio holdings.

Number of Shares
119,949
Previous 119,949 -0.0%
Holding current value
$64,772
Previous $95,000 20.0%
% of portfolio
0.12%
Previous 0.13%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022

BUY
$0.5 - $1.06 $59,974 - $127,145
119,949 New
119,949 $96,000

Others Institutions Holding MTNB

About Matinas BioPharma Holdings, Inc.


  • Ticker MTNB
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 216,864,992
  • Market Cap $117M
  • Description
  • Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of various product candidates. It develops products using its lipid nanocrystal (LNC) platform technology. The company's LNC delivery technology platform utilizes lipid nano-crystals for the delivery of small molecules, nucleic ...
More about MTNB
Track This Portfolio

Track Kingsbury Capital Investment Advisors LLC Portfolio

Follow Kingsbury Capital Investment Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kingsbury Capital Investment Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kingsbury Capital Investment Advisors LLC with notifications on news.